基于人群队列的荟萃分析:溃疡性结肠炎和克罗恩病患者的当代手术风险。
Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts.
机构信息
Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California.
Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada.
出版信息
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2031-2045.e11. doi: 10.1016/j.cgh.2020.10.039. Epub 2020 Oct 27.
BACKGROUND & AIMS: We conducted a systematic review with meta-analysis to estimate rates and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re-resection in patients with Crohn's disease (CD), focusing on contemporary risks.
METHODS
Through a systematic review until September 3, 2019, we identified population-based cohort studies that reported patient-level cumulative risk of surgery in patients with UC and CD. We evaluated overall and contemporary risk (after 2000) of surgery and analyzed time trends through mixed-effects meta-regression.
RESULTS
In patients with UC (26 studies), the overall 1-, 5-, and 10-year risks of colectomy was 4.0% (95% CI, 3.3-5.0), 8.8% (95% CI, 7.7-10.0), and 13.3% (95% CI, 11.3-15.5), respectively, with a decrease in risk over time (P < .001). Corresponding contemporary risks were 2.8% (95% CI, 2.0-3.9), 7.0% (95% CI, 5.7-8.6), and 9.6% (95% CI, 6.3-14.2), respectively. In patients with CD (22 studies), the overall 1-, 5-, and 10-year risk of surgery was 18.7% (95% CI, 15.0-23.0), 28.0% (95% CI, 24.0-32.4), and 39.5% (95% CI, 33.3-46.2), respectively, with a decrease in risk over time (P < .001). Corresponding contemporary risks were 12.3% (95% CI, 10.8-14.0), 18.0% (95% CI, 15.4-21.0), and 26.2% (95% CI, 23.4-29.4), respectively. In a meta-analysis of 8 studies in patients with CD with prior resection, the cumulative risk of a second resection at 5 and 10 years after the first resection was 17.7% (95% CI, 13.5-22.9) and 31.3% (95% CI, 24.1-39.6), respectively.
CONCLUSIONS
Patient-level risks of surgery have decreased significantly over time, with a 5-year cumulative risk of surgery of 7.0% in UC and 18.0% in CD in contemporary cohorts. This decrease may be related to early detection and/or better treatment.
背景与目的
我们进行了一项系统回顾和荟萃分析,以评估溃疡性结肠炎(UC)患者行结肠切除术和克罗恩病(CD)患者行原发性和再次切除术的发生率和趋势,并重点关注当代风险。
方法
通过系统回顾,我们确定了截至 2019 年 9 月 3 日报告 UC 和 CD 患者手术累积风险的基于人群的队列研究。我们评估了 UC 患者的总体和当代(2000 年后)手术风险,并通过混合效应荟萃回归分析时间趋势。
结果
在 UC 患者(26 项研究)中,结肠切除术的 1 年、5 年和 10 年总体风险分别为 4.0%(95%CI,3.3-5.0)、8.8%(95%CI,7.7-10.0)和 13.3%(95%CI,11.3-15.5),随着时间的推移风险呈下降趋势(P<0.001)。相应的当代风险分别为 2.8%(95%CI,2.0-3.9)、7.0%(95%CI,5.7-8.6)和 9.6%(95%CI,6.3-14.2)。在 CD 患者(22 项研究)中,手术的 1 年、5 年和 10 年总体风险分别为 18.7%(95%CI,15.0-23.0)、28.0%(95%CI,24.0-32.4)和 39.5%(95%CI,33.3-46.2),随着时间的推移风险呈下降趋势(P<0.001)。相应的当代风险分别为 12.3%(95%CI,10.8-14.0)、18.0%(95%CI,15.4-21.0)和 26.2%(95%CI,23.4-29.4)。在一项对 8 项 CD 患者既往切除术后再次切除的研究进行的荟萃分析中,首次切除术后 5 年和 10 年的第二次切除累积风险分别为 17.7%(95%CI,13.5-22.9)和 31.3%(95%CI,24.1-39.6)。
结论
随着时间的推移,患者手术风险显著降低,UC 患者的 5 年累积手术风险为 7.0%,CD 患者为 18.0%。这种下降可能与早期发现和/或更好的治疗有关。
相似文献
Clin Gastroenterol Hepatol. 2021-10
Clin Gastroenterol Hepatol. 2022-5
Clin Gastroenterol Hepatol. 2020-10
引用本文的文献
Therap Adv Gastroenterol. 2025-8-19
GE Port J Gastroenterol. 2024-11-5
Surg Endosc. 2025-7-7
BMJ Open Gastroenterol. 2025-6-19
本文引用的文献
Aliment Pharmacol Ther. 2019-10-17
Clin Gastroenterol Hepatol. 2020-8
Clin Gastroenterol Hepatol. 2020-4
Gastroenterology. 2019-1-10
Clin Gastroenterol Hepatol. 2018-12-21